Atlas Trials

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Clinical trial NCT00619112 · COMPLETED

Trial details

NCT number
NCT00619112
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Central Nervous System Neoplasm
Start date
2007-10-01
Primary completion
2011-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.